Evolution of Multiple Domains of the HIV-1 Envelope Glycoprotein during Coreceptor Switch with CCR5 Antagonist Therapy

HIV-1 uses CD4 as a receptor and chemokine receptors CCR5 and/or CXCR4 as coreceptors. CCR5 antagonists are a class of antiretrovirals used to inhibit viral entry. Phenotypic prediction algorithms such as Geno2Pheno are used to assess CCR5 antagonist eligibility, for which the V3 region is screened....

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Yueqi, Wu, Ellen, Gao, Xiang, Zhang, Jie, Martin, John C., Rosa, Bruce A., Mitreva, Makedonka, Ratner, Lee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431240/
https://www.ncbi.nlm.nih.gov/pubmed/35727047
http://dx.doi.org/10.1128/spectrum.00725-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431240/
https://www.ncbi.nlm.nih.gov/pubmed/35727047
http://dx.doi.org/10.1128/spectrum.00725-22

Ejemplares similares